These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Verapamil in ventricular tachycardia. Hasin Y; Kriwisky M; Gotsman MS Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466 [TBL] [Abstract][Full Text] [Related]
8. [Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature]. Delise P; Raviele A; Di Pede F; D'Este D; Bonso A; Piccolo E G Ital Cardiol; 1985 Jan; 15(1):54-62. PubMed ID: 4007354 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related]
10. Entrainment of idiopathic ventricular tachycardia of left ventricular origin with evidence for reentry with an area of slow conduction and effect of verapamil. Okumura K; Matsuyama K; Miyagi H; Tsuchiya T; Yasue H Am J Cardiol; 1988 Oct; 62(10 Pt 1):727-32. PubMed ID: 3421173 [TBL] [Abstract][Full Text] [Related]
11. Verapamil in idiopathic ventricular tachycardia of right bundle branch block morphology: observations during electrophysiologic and exercise testing. Sethi KK; Manoharan S; Mohan JC; Gupta MP Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):8-16. PubMed ID: 2419859 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic paroxysmal ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation: a unique clinical entity with specific properties. Lin FC; Finley CD; Rahimtoola SH; Wu D Am J Cardiol; 1983 Jul; 52(1):95-100. PubMed ID: 6858937 [TBL] [Abstract][Full Text] [Related]
14. [Effects of verapamil and disopyramide phosphate on the termination, reinduction and long-term prevention of paroxysmal supraventricular tachycardia]. Tsuchioka Y; Nakagawa H; Yamagata T; Sakura E; Hashimoto M; Okamoto M; Matsuura H; Kajiyama G Kokyu To Junkan; 1990 Mar; 38(3):243-8. PubMed ID: 2109870 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous adenosine on verapamil-sensitive "idiopathic" ventricular tachycardia. Griffith MJ; Garratt CJ; Rowland E; Ward DE; Camm AJ Am J Cardiol; 1994 Apr; 73(11):759-64. PubMed ID: 8160612 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease. Lee KL; Lauer MR; Young C; Lai WT; Tai YT; Chun H; Liem LB; Sung RJ Am J Cardiol; 1996 May; 77(11):967-73. PubMed ID: 8644647 [TBL] [Abstract][Full Text] [Related]
18. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide. Widerhorn J; Sager PT; Rahimtoola SH; Bhandari AK Pacing Clin Electrophysiol; 1991 Mar; 14(3):420-6. PubMed ID: 1708872 [TBL] [Abstract][Full Text] [Related]
19. Hazards of intravenous verapamil for sustained ventricular tachycardia. Buxton AE; Marchlinski FE; Doherty JU; Flores B; Josephson ME Am J Cardiol; 1987 May; 59(12):1107-10. PubMed ID: 3578051 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of Vanghan Williams classification for treatment of ventricular tachycardia: study of class IA and IB antiarrhythmic agents. Kasanuki H; Ohnishi S; Tanaka E; Hirosawa K Jpn Circ J; 1988 Mar; 52(3):280-8. PubMed ID: 3373720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]